Benefit-risk assessment of diacerein in the treatment of osteoarthritis.

Abstract

Osteoarthritis (OA) is the leading musculoskeletal cause of disability. Despite this, there is no consensus on the precise definition of OA and what is the best treatment to improve symptoms and slow disease progression. Current pharmacological treatments include analgesics, non-steroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase (COX) inhibitors… (More)
DOI: 10.1007/s40264-015-0266-z

4 Figures and Tables

Topics

Statistics

020406020162017
Citations per Year

Citation Velocity: 13

Averaging 13 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.
  • Presentations referencing similar topics